United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 20, 2026 · Filed Aug 21, 2026

On Aug 20, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$521.02 for US$4.95M under a trading plan, leaving 324,443 shares. Filed Aug 21, 2026 (Form 4).

Sold
9,500 shares
Price
US$521.02 average (US$518.45 to US$526.97)
Value
US$4.95M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 20, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 20, 2026Common StockSale976US$518.45332,967Indirect
Aug 20, 2026Common StockSale1,504US$519.51331,463Indirect
Aug 20, 2026Common StockSale2,357US$520.46329,106Indirect
Aug 20, 2026Common StockSale2,470US$521.39326,636Indirect
Aug 20, 2026Common StockSale960US$522.37325,676Indirect
Aug 20, 2026Common StockSale800US$523.26324,876Indirect
Aug 20, 2026Common StockSale240US$525.10324,636Indirect
Aug 20, 2026Common StockSale193US$526.97324,443Indirect

Source

View original at SEC

Related